Antimicrobial Agents Practice Questions

Q: What is the drug of choice for late East African Trypanosomiasis?

Melarsoprol. **Explanation:** The treatment of African Trypanosomiasis (Sleeping Sickness) is determined by the species (*T. brucei gambiense* vs. *rhodesiense*) and the stage of the disease (Early/Hemic-lymphatic vs. Late/Meningoencephalitic). **Why Melarsoprol is correct:** **Melarsoprol** is the drug of choice for **late-stage East African Trypanosomiasis** (*T. b. rhodesiense*). In the late stage, the parasite crosses the blood-brain barrier (BBB). Melarsoprol is an organic arsenical compound that is highly lipid-soluble, allowing it to achieve therapeutic concentrations in the CNS to kill the parasites. **Analysis of Incorrect Options:** * **Pentamidine (A):** Used for the **early stage** of West African Trypanosomiasis (*T. b. gambiense*). It does not cross the BBB. * **Suramin (B):** The drug of choice for the **early stage** of East African Trypanosomiasis (*T. b. rhodesiense*). Like pentamidine, it lacks CNS penetration. * **Nifurtimox (D):** Primarily used for **Chagas disease** (American Trypanosomiasis). It is also used in combination with Eflornithine (NECT) for late-stage West African Trypanosomiasis, but not as monotherapy for the East African variety. **High-Yield Clinical Pearls for NEET-PG:** 1. **Toxicity:** Melarsoprol is highly toxic; the most feared side effect is **reactive encephalopathy** (seen in 5-10% of patients), which can be fatal. 2. **West vs. East:** Remember **"EAR"** for East African = **S**uramin (Early) and **M**elarsoprol (Late). 3. **Eflornithine:** Known as the "resurrection drug," it is the drug of choice for late-stage West African Trypanosomiasis but is **ineffective** against the East African species.

Q: What is the daily dose of isoniazid in the treatment of tuberculosis?

5 mg/kg body weight. **Explanation:** The standard daily dose of **Isoniazid (INH)** for the treatment of tuberculosis in adults is **5 mg/kg body weight** (maximum 300 mg per day). This dosage is optimized to maintain therapeutic efficacy while minimizing the risk of dose-dependent toxicity. **Why Option A is correct:** Isoniazid is a bactericidal drug that inhibits the synthesis of mycolic acids, essential components of the mycobacterial cell wall. At a dose of 5 mg/kg, it achieves plasma concentrations significantly higher than the Minimum Inhibitory Concentration (MIC) for *M. tuberculosis*, effectively killing rapidly dividing intra- and extracellular bacilli. **Why other options are incorrect:** * **Option B (10 mg/kg):** This is the standard daily dose for **Rifampicin** (up to 600 mg) and is also the recommended dose for Isoniazid in **pediatric patients** (10–15 mg/kg) due to their faster metabolism. * **Options C & D (15-20 mg/kg):** These doses are excessively high for daily administration in adults and would significantly increase the risk of hepatotoxicity and peripheral neuropathy. However, 15 mg/kg is sometimes used in intermittent (thrice-weekly) supervised regimens. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits *inhA* and *kasA* enzymes involved in mycolic acid synthesis; it is a **prodrug** activated by the mycobacterial **KatG** enzyme. * **Adverse Effects:** 1. **Peripheral Neuropathy:** Caused by interference with Pyridoxine (Vitamin B6) metabolism. Always co-prescribe **10–50 mg/day of Vitamin B6**. 2. **Hepatotoxicity:** The most common serious side effect; risk increases with age and alcohol use. * **Metabolism:** Occurs via **Acetylation** (Genetic polymorphism: Fast vs. Slow acetylators). Slow acetylators are more prone to neuropathy. * **Drug of Choice:** For Latent TB infection (Chemoprophylaxis).

Q: What is the drug of choice for actinomycosis?

Penicillin. **Explanation:** **Actinomycosis** is a chronic, granulomatous infection caused by *Actinomyces israelii*, a Gram-positive, anaerobic, non-acid-fast branching filamentous bacterium. **1. Why Penicillin is the Correct Answer:** **Penicillin G** (intravenous) followed by **Penicillin V** (oral) is the definitive **drug of choice**. *Actinomyces* species are exquisitely sensitive to beta-lactams. Because the infection is characterized by dense fibrosis and "sulfur granules" (microcolonies) which limit drug penetration, high-dose, prolonged therapy (6–12 months) is required to prevent relapse. **2. Analysis of Incorrect Options:** * **Sulfonamides (B):** While historically used, they are significantly less effective than Penicillin and are not considered first-line. They are primarily used for *Nocardia* (which is acid-fast), often leading to confusion between the two. * **Tetracycline/Doxycycline (C):** These are considered **second-line** agents or the drug of choice only in patients with a **Penicillin allergy**. * **Azithromycin (D):** Macrolides have some activity but are not standard therapy and lack the robust clinical evidence supporting Penicillin or Tetracyclines for this specific infection. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Lumpy Jaw":** The most common presentation is cervicofacial actinomycosis, often following dental procedures or poor oral hygiene. * **Sulfur Granules:** A hallmark diagnostic finding in abscess pus (yellowish specks), though they do not actually contain sulfur. * **Differential Diagnosis:** Always distinguish from *Nocardia*. * *Actinomyces*: Anaerobic, Non-acid-fast, Rx: **Penicillin**. * *Nocardia*: Aerobic, Weakly acid-fast, Rx: **Cotrimoxazole**. * **IUD Association:** Pelvic actinomycosis is strongly associated with the long-term use of intrauterine contraceptive devices.

Q: What is the antibiotic of choice in patients with penicillin sensitivity?

Erythromycin. The correct answer is **Erythromycin**. **Why Erythromycin is the correct choice:** Erythromycin, a macrolide antibiotic, is classically considered the first-line alternative for patients with a documented **Type-I hypersensitivity (allergy) to Penicillin** [1]. This is because Erythromycin shares a similar antimicrobial spectrum with Penicillin G (targeting primarily Gram-positive cocci and bacilli), but it is chemically unrelated to beta-lactams. Therefore, there is no cross-reactivity, making it safe for penicillin-sensitive individuals in treating infections like streptococcal pharyngitis [2], diphtheria [3], and syphilis. **Analysis of incorrect options:** * **Streptomycin:** This is an aminoglycoside primarily used for tuberculosis and certain Gram-negative infections. It does not cover the typical Gram-positive spectrum of penicillin and carries risks of ototoxicity and nephrotoxicity. * **Tetracycline:** While broad-spectrum, it is bacteriostatic and has a different clinical profile. It is not the preferred substitute for routine penicillin-indicated infections due to widespread resistance and side effects (e.g., effects on teeth and bones). * **Chloramphenicol:** Though broad-spectrum, its use is severely restricted due to the risk of life-threatening bone marrow suppression (Aplastic Anemia) and Gray Baby Syndrome. It is never a first-line alternative for simple penicillin sensitivity. **NEET-PG High-Yield Pearls:** * **Cross-Reactivity:** Patients with penicillin allergy have a **5-10% risk** of cross-reactivity with first-generation Cephalosporins. However, Macrolides (Erythromycin, Azithromycin) have **zero** cross-reactivity. * **Drug of Choice (DOC):** Erythromycin is the DOC for *Legionella*, *Mycoplasma pneumoniae*, and *Diphtheria* (carriers and cases). * **Side Effect:** Erythromycin is a motilin agonist; it can cause epigastric pain and is sometimes used off-label for gastroparesis.

Q: What is the drug of choice for prophylaxis of meningococcal meningitis in a pregnant female after contact with a case?

Ceftriaxone. **Explanation:** The goal of post-exposure prophylaxis (PEP) for meningococcal meningitis (*Neisseria meningitidis*) is to eradicate nasopharyngeal carriage in close contacts to prevent invasive disease and further transmission. **Why Ceftriaxone is the Correct Choice:** In the general population, **Rifampin** (or Ciprofloxacin) is typically the drug of choice. However, in **pregnant females**, Rifampin is avoided due to potential teratogenicity (though evidence is limited, safer alternatives exist). **Ceftriaxone (250 mg IM single dose)** is the drug of choice for pregnant women because it is highly effective at eradicating the carrier state and has an excellent safety profile (Category B) during pregnancy. **Analysis of Incorrect Options:** * **A. Ciprofloxacin:** While a common single-dose oral option for adults, it is generally avoided in pregnancy due to concerns regarding fetal cartilage damage (arthropathy). * **C. Cefalexin:** This is a first-generation cephalosporin. It does not achieve adequate concentrations in the nasopharyngeal mucosa or cross the blood-brain barrier effectively enough to be used for meningococcal prophylaxis. * **D. Rifabutin:** While related to Rifampin, it is primarily used for *Mycobacterium avium* complex (MAC) prophylaxis in HIV patients and is not the standard of care for meningococcal PEP. **High-Yield Clinical Pearls for NEET-PG:** * **Standard DOC for PEP:** Rifampin (600 mg BID for 2 days). * **Alternative for Adults:** Ciprofloxacin (500 mg single oral dose). * **DOC for Pregnancy/Children:** Ceftriaxone (250 mg IM single dose). * **Close Contacts Defined:** Household members, daycare center contacts, or anyone directly exposed to the patient's oral secretions (e.g., kissing, intubation) within 7 days before symptom onset.

Q: What is the recommended daily dose of Isoniazid for children?

10-20 mg/kg. The correct answer is **B. 10-20 mg/kg**. ### **Explanation** Isoniazid (INH) is a cornerstone of Antitubercular Therapy (ATT). In pediatric patients, the metabolic rate of drugs is generally higher than in adults. According to the **WHO** and the **National Tuberculosis Elimination Program (NTEP)** guidelines, the recommended daily dose of Isoniazid for children is **10-15 mg/kg** (with a range extending up to **20 mg/kg** in some clinical scenarios). This higher weight-based dosage compared to adults is necessary to achieve therapeutic plasma concentrations, as children are often "rapid acetylators." ### **Analysis of Options** * **Option A (5 mg/kg):** This is the standard daily dose for **adults**, not children. Using this dose in children would lead to sub-therapeutic levels and potential treatment failure. * **Option C (15-25 mg/kg):** This range is typically associated with **Ethambutol** (15-25 mg/kg) or Pyrazinamide (30-35 mg/kg) in certain pediatric protocols. * **Option D (20-40 mg/kg):** This is an excessively high dose for Isoniazid and would significantly increase the risk of hepatotoxicity and neurotoxicity. ### **High-Yield Clinical Pearls for NEET-PG** * **Mechanism of Action:** Inhibits the synthesis of **mycolic acids** by targeting the *InhA* enzyme. * **Metabolism:** Metabolized via **Acetylation** (Phase II reaction). Genetic polymorphism leads to "Fast" and "Slow" acetylators. * **Side Effects:** Peripheral neuropathy (due to **Vitamin B6/Pyridoxine deficiency**) and Hepatotoxicity (most common). * **Prophylaxis:** Isoniazid is the drug of choice for Chemoprophylaxis in household contacts of TB patients (dose: 10 mg/kg for children). * **Supplementation:** Always co-prescribe **Pyridoxine (10-25 mg/day)** in children to prevent peripheral neuropathy.

Q: Bacitracin is a:

Topical antibiotic. **Explanation:** **Bacitracin** is a polypeptide antibiotic primarily used as a **topical agent**. Its mechanism of action involves inhibiting cell wall synthesis by interfering with the dephosphorylation of the C55-isoprenyl pyrophosphate (bactoprenol), which transports peptidoglycan subunits across the cell membrane. **Why Option B is Correct:** Bacitracin is highly effective against Gram-positive bacteria (like *Staphylococci* and *Streptococci*). However, it is **highly nephrotoxic** when administered systemically. Therefore, its clinical use is strictly restricted to topical applications (ointments/creams) for skin infections, wounds, and ophthalmic preparations to ensure local efficacy without systemic toxicity. **Why Other Options are Incorrect:** * **Option A (Oral):** Bacitracin is not absorbed from the gastrointestinal tract. While some non-absorbable antibiotics are used for bowel preparation (e.g., Neomycin), Bacitracin is not used this way. * **Option C (Parenteral):** Systemic (parenteral) administration is obsolete due to severe **nephrotoxicity** (tubular and glomerular damage). It was historically used for infant pneumonia but has been replaced by safer alternatives. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Inhibits the lipid carrier **bactoprenol** (unlike Penicillins, which inhibit transpeptidation). * **Spectrum:** Primarily Gram-positive organisms. * **Triple Antibiotic Ointment:** Bacitracin is often combined with **Neomycin** and **Polymyxin B** (Neosporin) to provide broad-spectrum coverage. * **Zinc Bacitracin:** The addition of zinc stabilizes the compound and enhances its antibacterial activity.

Q: Which of the following drugs is NOT effective against anaerobes?

Gentamicin. **Explanation:** The correct answer is **Gentamicin**. **1. Why Gentamicin is the correct answer:** Gentamicin is an **Aminoglycoside**. The transport of aminoglycosides across the bacterial cell membrane is an **oxygen-dependent active process**. In anaerobic environments, there is a lack of oxygen to drive this transport mechanism; therefore, the drug cannot enter the bacterial cell to reach its target (the 30S ribosome). Consequently, all aminoglycosides exhibit an **innate resistance** to obligate anaerobes. **2. Analysis of Incorrect Options:** * **Penicillin:** While many Gram-negative anaerobes produce beta-lactamases, Penicillin G remains highly effective against most **Gram-positive anaerobes** (e.g., *Peptostreptococcus*) and non-beta-lactamase-producing Gram-negative anaerobes (e.g., *Fusobacterium*). * **Chloramphenicol:** This is a broad-spectrum antibiotic with excellent tissue penetration and potent activity against most anaerobic bacteria, including *Bacteroides fragilis*. It is often reserved for serious anaerobic infections when other drugs are contraindicated. * **Clindamycin:** This is a classic anti-anaerobic agent. It is particularly effective against anaerobes "above the diaphragm" and is a first-line choice for lung abscesses and dental infections. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Anaerobic Coverage:** "Can't Breathe Air" (**C**lindamycin, **B**eta-lactams/Metronidazole, **A**minoglycosides = **NO**). * **Aminoglycoside Synergy:** Because they lack anaerobic activity, aminoglycosides are frequently combined with Beta-lactams (which disrupt cell wall synthesis) to facilitate drug entry and broaden the spectrum. * **Metronidazole** is the gold standard for anaerobes "below the diaphragm" (e.g., *B. fragilis*).

Q: Which of the following statements is false about Acyclovir?

It is effective against influenza. ### Explanation **1. Why Option B is the correct (False) statement:** Acyclovir is a narrow-spectrum antiviral agent specifically targeting the **Herpesvirus family** (HSV-1, HSV-2, and VZV) [1]. It is **ineffective against Influenza**, which is an RNA virus [2]. Influenza is treated with neuraminidase inhibitors (e.g., Oseltamivir) or M2 ion channel blockers (e.g., Amantadine). **2. Analysis of other options:** * **Option A (Mechanism):** Acyclovir is a guanosine analogue [2]. It undergoes initial phosphorylation by viral **thymidine kinase** to acyclovir monophosphate, then to triphosphate by host cell kinases [2]. This active form acts as a competitive inhibitor of **viral DNA polymerase** and causes **DNA chain termination**, thereby inhibiting replication [1]. * **Option C (Toxicity):** It has high selectivity and **low host toxicity** because the initial activation step requires a viral enzyme (thymidine kinase), which is absent in non-infected human cells [2]. * **Option D (Pharmacokinetics):** Acyclovir is primarily excreted unchanged via glomerular filtration and tubular secretion [1]. In patients with **renal impairment**, the drug can accumulate, leading to neurotoxicity or obstructive uropathy (crystalline nephropathy); hence, dose adjustment is mandatory [1]. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** Herpes Simplex Encephalitis, Genital Herpes, and Chickenpox/Zoster in immunocompromised patients. * **Resistance:** Most commonly due to the absence or mutation of the viral **thymidine kinase** enzyme [3]. * **Valacyclovir:** A prodrug of acyclovir with much higher oral bioavailability (the "Val" prefix often denotes improved bioavailability in antivirals) [1]. * **Side Effect:** Intravenous administration can cause **reversible crystalline nephropathy**; ensure adequate hydration.

Q: Erythromycin acts by binding to the 50S ribosomal subunit and interferes with which step of protein synthesis in bacteria?

Translocation. **Explanation:** **Mechanism of Action:** Erythromycin belongs to the **Macrolide** class of antibiotics. It exerts its bacteriostatic effect by reversibly binding to the **23S rRNA of the 50S ribosomal subunit**. This binding specifically inhibits the enzyme **peptidyl transferase** and prevents the **translocation** step. During translocation, the growing peptide chain moves from the A-site (aminoacyl) to the P-site (peptidyl) on the ribosome. By blocking this movement, erythromycin halts protein synthesis. **Analysis of Options:** * **Translocation (Correct):** This is the specific movement of the ribosome along the mRNA template. Macrolides (Erythromycin, Azithromycin, Clarithromycin) are classic inhibitors of this step. * **Transcription (Incorrect):** This is the process of DNA being copied into RNA, catalyzed by RNA polymerase. Drugs like **Rifampicin** inhibit this step. * **Translation (Incorrect):** While translocation is a *part* of translation, "translation" is too broad a term. The question asks for the specific step within the protein synthesis cycle. * **Transduction (Incorrect):** This is a process of horizontal gene transfer in bacteria mediated by **bacteriophages** (viruses), not a step in protein synthesis. **Clinical Pearls for NEET-PG:** * **Resistance Mechanism:** The most common mechanism of resistance to Macrolides is **methylation of the 23S rRNA** (via *erm* genes), which prevents drug binding. * **Prokinetic Effect:** Erythromycin acts as a **Motilin receptor agonist**, making it useful in treating diabetic gastroparesis. * **Drug Interactions:** Erythromycin is a potent **CYP3A4 inhibitor**, leading to increased levels of drugs like Theophylline, Warfarin, and Statins. * **Adverse Effect:** It is a notorious cause of **cholestatic jaundice** (especially the estolate salt) and QT interval prolongation.

Question 1

What is the drug of choice for late East African Trypanosomiasis?

Accepted Answer

Melarsoprol

Answer

Pentamidine

Answer

Suramine

Answer

Nifurtimox

Question 2

What is the daily dose of isoniazid in the treatment of tuberculosis?

Accepted Answer

5 mg/kg body weight

Answer

10 mg/kg body weight

Answer

20 mg/kg body weight

Answer

15 mg/kg body weight

Question 3

What is the drug of choice for actinomycosis?

Accepted Answer

Penicillin

Answer

Sulfonamides

Answer

Tetracycline

Answer

Azithromycin

Question 4

What is the antibiotic of choice in patients with penicillin sensitivity?

Accepted Answer

Erythromycin

Answer

Streptomycin

Answer

Tetracycline

Answer

Chloramphenicol

Question 5

What is the drug of choice for prophylaxis of meningococcal meningitis in a pregnant female after contact with a case?

Accepted Answer

Ceftriaxone

Answer

Ciprofloxacin

Answer

Cefalexin

Answer

Rifabutin

Question 6

What is the recommended daily dose of Isoniazid for children?

Accepted Answer

10-20 mg/kg

Answer

5 mg/kg

Answer

15-25 mg/kg

Answer

20-40 mg/kg

Question 7

Bacitracin is a:

Accepted Answer

Topical antibiotic

Answer

Oral antibiotic

Answer

Parenteral antibiotic

Answer

All of the above

Question 8

Which of the following drugs is NOT effective against anaerobes?

Accepted Answer

Gentamicin

Answer

Penicillin

Answer

Chloramphenicol

Answer

Clindamycin

Question 9

Which of the following statements is false about Acyclovir?

Accepted Answer

It is effective against influenza

Answer

It inhibits DNA synthesis and viral replication

Answer

It has low toxicity for host cells

Answer

Renal impairment necessitates dose reduction

Question 10

Erythromycin acts by binding to the 50S ribosomal subunit and interferes with which step of protein synthesis in bacteria?

Accepted Answer

Translocation

Answer

Transcription

Answer

Translation

Answer

Transduction

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?